The High Speed Cell Sorter Core (HSCS Core) provides the following services: 1. Cell sorting. A three laser, high speed cell sorter (MoFIo, DakoCytomation, Inc.) with a flexible configuration is housed in the HSCS laboratory. Dedicated technicians in the Core are responsible for all aspects of instrument operation. 2. Flow cytometric analysis. A three-color benchtop analytical instrument (BD FACScan) is available in the HSCS Core laboratory for self-service or supervised use by SCC members. 3. Sample preparation. For investigators lacking suitable infrastructure to prepare samples for flow cytometric analysis, the HSCS Core provides a range of technical assistance from experimental design to cell isolation, staining, and analysis. Flow cytometry is a powerful tool widely utilized in clinical oncology and cancer biology research. The HSCS Core was established to serve a growing number of investigators at the Washington University School of Medicine whose needs were not adequately met by existing cell sorting facilities on campus. A shared instrumentation grant from the NCRR provided funds for the purchase of a high speed cell sorter. Additional hardware and software were acquired with support from the SCC. The core is now a fully equipped state-of-the- art facility that strives to improve the quality of flow cytometry research performed in the SCC by assisting investigators in all phases of their experiments from planning to publication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-06
Application #
7287738
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
6
Fiscal Year
2006
Total Cost
$112,795
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Stephens, Calvin J; Kashentseva, Elena; Everett, William et al. (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. Gene Ther 25:139-156
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Copper, Tara Conway; Jeffe, Donna B; Ahmad, Fahd A et al. (2018) Emergency Information Forms for Children With Medical Complexity: A Qualitative Study. Pediatr Emerg Care :
McGill, Bryan E; Barve, Ruteja A; Maloney, Susan E et al. (2018) Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons. J Neurosci 38:200-219
Sharma, Piyush K; Dmitriev, Igor P; Kashentseva, Elena A et al. (2018) Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Ther 25:27-38
Liu, Ying; Colditz, Graham A; Rosner, Bernard A et al. (2018) Comparison of Performance Between a Short Categorized Lifestyle Exposure-based Colon Cancer Risk Prediction Tool and a Model Using Continuous Measures. Cancer Prev Res (Phila) 11:841-848
Dodson, Elizabeth A; Hipp, J Aaron; Lee, Jung Ae et al. (2018) Does Availability of Worksite Supports for Physical Activity Differ by Industry and Occupation? Am J Health Promot 32:517-526
Bauerle, Kevin T; Hutson, Irina; Scheller, Erica L et al. (2018) Glucocorticoid Receptor Signaling Is Not Required for In Vivo Adipogenesis. Endocrinology 159:2050-2061
Garbow, Joel R; Tsien, Christina I; Beeman, Scott C (2018) Preclinical MRI: Studies of the irradiated brain. J Magn Reson 292:73-81
Chiu, Ami; Hartz, Sarah; Smock, Nina et al. (2018) Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication. J Neuroimmune Pharmacol 13:430-437

Showing the most recent 10 out of 1244 publications